Stockscreener 앱 받기
8.34
11.05%
0.83
시간 외 거래:
8.42
0.08
+0.96%
Bausch Health Companies Inc 주식(BHC)의 최신 뉴스
Bausch Health Stake Rises for Paulson Capital; Brett Icahn and Steven Miller Resign as Board Directors - MarketScreener
Bausch Health stock soars after Paulson increases stake - Investing.com
Bausch Health stock rises on insider purchase (BHC:NYSE) - Seeking Alpha
Bausch Health (BHC) Rebounds 15.8% on Bargain-Hunting - MSN
Bausch Health Brief: Brett M. Icahn and Steven D. Miller Have Resigned from the Board of Directors - MarketScreener
Bausch Health Brief: Announcing Increase in Shareholding by its Chairperson of the Board and Board Changes - MarketScreener
Bausch Health's Shareholder and Board Shake-Up: A Strategic Inflection Point for Value Creation? - AInvest
Paulson Capital increases stake in Bausch Health to 19.13% - Investing.com
Paulson increases ownership of Bausch Health common shares - TipRanks
Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes - ACCESS Newswire
19.13% Ownership Stake: Bausch Health Chairman Paulson Acquires Icahn's Entire Position in Major Shakeup - Stock Titan
Bausch Health’s Strong Q2 Results: What’s Next? - StocksToTrade
Bausch Health rises after $300M worth insider purchase - MSN
Bausch Health's Insider Purchase: A Strategic Indicator for Value Investors - AInvest
What is Bausch Health Companies Inc.’s TAM (Total Addressable Market)Inflation Watch & High Accuracy Trade Alerts - sundaytimes.kr
Toronto stocks subdued as investors await pivotal US-Russia meet - MarketScreener
Paulson John buys $312 million in Bausch Health (BHC) shares By Investing.com - Investing.com Canada
Paulson John buys $312 million in Bausch Health (BHC) shares - Investing.com
Bausch Health Companies Inc. Reversal Rally May Surprise BearsPortfolio Update Summary & Step-by-Step Swing Trade Plans - sundaytimes.kr
Resistance Break Could Fuel Bausch Health Companies Inc. RallyJuly 2025 Sentiment & Weekly High Momentum Picks - newsyoung.net
John Paulson buying at Bausch Health Companies (BHC) - The Globe and Mail
DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health - The Malaysian Reserve
Form PRE 14A Bausch Health Companies For: Oct 07 - StreetInsider
Durect and Bausch Health Merger on Track to Close in Q3 - AInvest
Bausch Health's Durect Acquisition: Strategic Valuation and Risk Mitigation in Biopharma M&A - AInvest
Biotech DURECT Gets $63M Buyout Offer from Bausch Health with $350M Future Payment Potential - Stock Titan
IBS in America: Despite advances, IBS remains a burden for many millions - Benzinga
Why Bausch Health Stock Surged By Nearly 20% (NYSE:BHC) - Seeking Alpha
Bausch Health reaffirms 2025 revenue target of $4.95B–$5.1B as debt reduction and pipeline expansion advance - MSN
Bausch Health Companies Inc. shares fall 1.65% premarket as TSX steadies with tech stocks rising. - AInvest
United States Epilepsy Drugs Market Trends and Company - GlobeNewswire
Is This a Bottoming Phase for Bausch Health Companies Inc.Intraday Trend Analysis for Fast Gains Released - metal.it
Bausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease Treatment - MSN
Is Bausch Health Companies Inc. Forming a Consolidation BaseShort Term Buy Zone Stock Alerts Signal Entry - metal.it
Saudi Arabia OTC Artificial Tears Market Forecast and - GlobeNewswire
Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical - Yahoo Finance
Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners - The Daily Corinthian
Bausch Health's $100K GI Health Scholarship Program Empowers 10 Students Despite Medical Challenges - Stock Titan
Bausch Health Companies Inc. shares fall 2.95% intraday as Toronto stocks climb to fresh highs. - AInvest
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease - biomb.ca
Bausch Health Companies Inc. shares rise 2.68% intraday after Viatris Inc. appoints David Simmons to its Board of Directors. - AInvest
Liver Cirrhosis Market Predicted to See Upsurge Through 2034, Highlights DelveInsight | Pfizer, GlaxoSmithKline, Bausch Health, Bristol-Myers Squibb, Mallinckrodt, Cumberland - Barchart.com
Saudi Arabia Vision Care Market Forecast and Company - GlobeNewswire
Saudi Arabia Vision Care Market Forecast and Company Analysis Report 2025-2033 Featuring Essilor, J&J, Bausch Health, Novartis, Grand Vision, Carl Zeiss, Valeant, Paragon Vision Science, Menicon - Yahoo Finance
Is Bausch Health Companies Inc. a growth stock or a value stockFree Daily Trading Room Entry - Jammu Links News
What are the technical indicators suggesting about Bausch Health Companies Inc.Fastest-growing stock picks - Jammu Links News
What are analysts’ price targets for Bausch Health Companies Inc. in the next 12 monthsBuild a diversified portfolio for stability - Jammu Links News
What institutional investors are buying Bausch Health Companies Inc. stockBuild a winning portfolio with smart picks - Jammu Links News
What analysts say about Bausch Health Companies Inc. stockInvest confidently with professional guidance - Jammu Links News
Does Bausch Health Companies Inc. stock perform well during market downturnsGet timely alerts on market opportunities - Jammu Links News
How does Bausch Health Companies Inc. compare to its industry peersConsistently superior profits - Jammu Links News
What catalysts could drive Bausch Health Companies Inc. stock higher in 2025Track high-yield stocks before they peak - Jammu Links News
Lacklustre Performance Is Driving Bausch Health Companies Inc.'s (NYSE:BHC) 25% Price Drop - 富途牛牛
How many analysts rate Bausch Health Companies Inc. as a “Buy”Discover market opportunities with real-time data - Jammu Links News
2.80%
0.22%
자본화:
|
볼륨(24시간):